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Abstract 
The health background management and
outcomes of 5 pregnancies in 4 women affect-
ed by Cooley Disease, from Paediatric Institute
of Catania University, are described, consider-
ing the preconceptual guidances and cares for
such patients. These patients were selected
among a group of 100 thalassemic women
divided into three subgroups, according to
their first and successive menstruation char-
acteristics: i) patients with primitive amenor-
rhoea, ii) patients with secondary amenor-
rhoea and iii) patients with normal menstrua-
tion. Only one woman, affected by primitive
amenorrhoea, needed the induction of ovula-
tion. A precise and detailed pre-pregnancy
assessment was effected before each concep-
tion. This was constituted by a series of
essays, including checks for diabetes and
hypothyroidism, for B and C hepatitis and for
blood group antibodies. Moreover were evalu-
ated: cardiac function, rubella immunity and
transaminases. Other pregnancy monitoring,
and cares during labour and delivery were
effected according to usual obstetrics practice.
All the women were in labour when she
were 38 week pregnant, and the outcome were
five healthy babies born at term, weighting
between 2600 and 3200gs. The only complica-
tion was the Caesarean section. The improve-
ments of current treatments, especially in the
management of iron deposits, the prolongation
of survival rate, will result in a continuous
increase of pregnancies in thalassemic
women. Pregnancy is now a real possibility for
women affected by such disease. We are fur-
thermore studying the possibility to collect the
fetus' umbilical cord blood, after the delivery,
to attempt eterologus transplantation to his
mother trying to get a complete marrow recon-
stitution. 
Introduction
Beta Thalassemia major, also called Cooley
disease, is a severe transfusion-dependent
anaemia which often causes infertility due to
the iron deposits in endocrine organs follow-
ing multiple blood transfusions, needed to care
this illness. Gonadal function is impaired in
the majority of the patients affected by the
homozygous kind of this disease and, especial-
ly in females, this is expressed either by a
delay in the onset of puberty and menstruation
or by secondary amenorrhoea.1 The common-
est abnormality was hypogonadotropic hypogo-
nadism, but the relatively high prevalence of
other endocrine impairments, causing multi-
ple endocrinopathies, is also well recognised.
These kind of endocrine complications are
directly related to the serum ferritin level.2 The
aetiology of the above mentioned reproductive
disorders is linked to an anatomical and func-
tional disarray of the components of the cen-
tral nervous system-gonadal axis and the func-
tionality is often impaired at all three levels,
i.e. gonads, anterior pituitary and hypothala-
mus.3-5 Up to the end of 1980 there were only
some reports of pregnancy in patients with
beta Thalassemia major and, only few of them
were carried out successfully.6-8 Nowadays,
thanks to improved paediatric and haemato-
logical cares, patients affected by Cooley dis-
ease may live on to be forty or fifty, and can
enjoy a quite regular standard of life. So that,
maintaining a strict therapeutic regimen,
women regularly transfused and well chelated
can attempt to become pregnant.9-12 In this
report we describe the evolution and the suc-
cessful outcome of five at term pregnancies
carried out by four women affected by transfu-
sion dependent beta Thalassemia. In review-
ing the cares and the complications during and
after their pregnancies, we discuss the issue
concerning the appropriate preconception
counselling of such patients. 
Materials and Methods 
For several years we have been following one
hundred women affected by transfusion
dependent beta Thalassemia major, diagnosed
when they were between 6 and 8 months old,
from the endocrine and reproductive point of
view. All of them, who attended the Paediatric
Institute of Catania University, were aged
between 23 to 29 and received a blood transfu-
sion every 15-20 days, in order to maintain the
haemoglobin concentration above 10 g/dL; and
were in strict desferrioxamine chelating thera-
py, to avoid excessive iron overloads. The
patients have been divided into three groups
according to their first and successive menstru-
ation characteristics: i) patients with primitive
amenorrhoea, ii) patients with secondary
amenorrhoea and iii) patients with normal
menstruation. In detail twenty out of these
women got married: four were affected by prim-
itive amenorrhoea; six were affected by second-
ary one and the remaining ten women had nor-
mal menstruation. Finally five pregnancies
occurred among these twenty women: two
among the patients affected respectively by
primitive and secondary amenorrhoea, and
three were carried out by women with sponta-
neous menstruation. Considering as to the last
three pregnancies, it is remarkable that to this
group belonged a woman that had two success-
ful childbirths; so the total number of women
we followed was four (Figures 1, 2; Table 1).
Average values of ferritin fluctuated between
500 and 1000 ng/mL, and transaminases were
between 25 and 100 U/L. All of them were vacci-
nated against Hepatitis B Virus (HBV), and two
were splenectomized, particularly the woman
affected by primitive amenorrhoea and one of
those with normal periods. Only the woman
affected by primitive amenorrhoea needed the
induction of ovulation to stimulate her pregnan-
cy. Evaluation of eligibility depends upon the
results of a series of examinations regarding
hearth, kidneys, thyroid, pancreas and periph-
eral arteries. Haemo siderotic parenchimal
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deterioration, particularly of the myocardium,
makes these patients potentially fragile, while
the induction of ovulation may be a hard stress
test even for a healthy woman. All the other
women had spontaneous and physiological
pregnancies. It is finally important to underline
that all the partners of these women were neg-
ative as regards the thalassemic trait. According
to the guidelines previously established by
Susan M. Tuck,13 a precise and detailed pre-
pregnancy assessment was effected before each
conception. This was constituted by a series of
clinical and laboratory essays, including checks
for diabetes and hypothyroidism, for B and C
hepatitis and for blood group antibodies.
Cardiac function was assessed symptomatically
and by echocardiography and exercise electro-
cardiography. Rubella immunity was checked
and immunisation was given when the woman
was found to be susceptible. During pregnancy
the monitoring of all these factors continued,
including frequent checks of aminotransferase
(AST and ALT transaminases). The frequency of
blood transfusion had to be increased, the aim
being to maintain the pre-transfusion haemo-
globin concentration. Desferrioxamine therapy
was stopped as soon as pregnancy was diag-
nosed, because using this drug during gestation
could notoriously induce teratogenic effects on
the foetus, but the average values of ferritin
were just a little higher than the normal range
observed. Probably the foetus, due to a particu-
lar chelating activity, maintains it during gesta-
tion. This therapy was quickly resumed after
delivery.14 Other pregnancy monitoring, such as
for blood pressure, for proteinuria and for fetal
growth, and cares during labour and delivery
were effected according to usual obstetrics prac-
tice and criteria. 
Results
Only one out of the five pregnancies we have
followed needed the induction of ovulation.
Moreover a same woman carried out two of
them. All the women were in labour when she
were 38 week pregnant, and the outcome were
five healthy babies born at term weighting
between 2600 and 3200gs. The caesarean deliv-
ery was preferred because of the frequent infer-
tility/sterility that occurs in the natural history
of such kind of patients. All of these women
were neither HIV positive nor suffered from dia-
betes, however they were controlled with a diet.
All of them reported transaminases raising, but
only in one case it was necessary to practice a
therapy based on silimarina. Moreover all of
them had transfusion-transmitted C hepatitis
prior to pregnancy, but only the one affected by
secondary amenorrhoea received curses of
interferon two years before embarking on preg-
nancy, because she showed to be positive for
HCV-RNA. Four out of the babies born were HCV
negative, while only one was HCV positive but
HCV-RNA negative, so that it was not necessary
to prescribe a therapy.
Finally, there were neither cardiac dysfunc-
tions nor kidney diseases reported, or other
important affections.
Discussion 
We believe that several ethical and theoretical
questions should be evaluated before the obser-
vation of technical problems. We should never
forget that Beta thalassemic are fragile patients
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Table 1. Table expressing the number of married women, the pregnancies, the medium
age and the amount of each group, according to a subdivision in three categories -
Normal menstruation, Secondary Amenorrhoea and Primitive Amenorrhoea – in refer-
ence to the total amount of the 100 patients we studied.
Menstruation  Normal Secondary Primary
characteristics menstruation amenorrhea amenorrhea
Married women 10 6 4
Number of pregnancy 3 (30%) 1 (16.6%) 1 (25%)
Spontaneous pregnancy 3 (100%) 1 (100%) -
Induced pregnancy - - 1 (100%)
Medium Age 21.4±2.2 23.7±1.9 25.1±3.4
Figure 1. Flow chart representing the distribution of 100 women affected by Beta
Thalassemia major subdivided in three categories, according to their menstruation char-
acteristics; considering if they are married or singles, and the number of pregnancies car-
ried out by each group.
Figure 2. Graphic expressing the percentage of married women in reference to each group
in which we subdivided them. 
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who are knowingly exposed to a large quantity of
risks. It is the doctor’s responsibility to decide
which patient can afford ovulation induction,
when needed, pregnancy and labour, with an
acceptable degree of risk, and which are the lim-
its of this risk. As regards the possibility to
induce a pregnancy in women affected by such
disease, this activity was judged to be perfectly
moral from the chatolic point of view by the
Center for Bioethics of the Chatolic University of
the Sacred Heart, Rome, as it was explained in
previous studies regarding this matter.15
Finally, the improvements of current con-
ventional treatments, especially in the man-
agement of iron deposits, the prolongation of
survival rate, and the new approaches to
assisted conception, when needed, will result
in a continuous increase of pregnancies in
women affected by beta Thalassemia.
According to the several advances in treat-
ment, occurred from the 1980s, and to pericon-
ceptional counselling - concerning the contin-
uation of pregnancy only in women in good
general conditions - intrauterine growth retar-
dation, foetal loss and preterm labour are
remarkably reducing. 
Concluding we can state that pregnancy is
now a real possibility for women affected by
Cooley disease that are regularly transfused
and well chelated. Pregnancy does not have a
deleterious effect on the course of their dis-
ease, and on the general well being of the foe-
tus. It seems, in fact, that the evaluation of car-
diac function, in combination with a low iron
load and satisfactory endocrine and hepatic
controls can ensure a pregnancy outcome with
minimal adverse effects, and not severe obstet-
ric complications except for the high incidence
of caesarean sections.16
Then it is possible to think about a normal
pregnancy without fetal loss, foetus' intrauter-
ine growth retardation and preterm labour, like
it is commonly believed. We are furthermore
studying the possibility to collect a good quan-
tity of umbilical cord blood of the foetus, after
the delivery and before placental detachment,
to attempt eterologus transplantation to the
mother (Figure 3).17 This is to be hoped, espe-
cially if the mother is totally HLA-matched or
also partially matched with her son, because
umbilical cord blood has shown to possess a
significant quantity of CD34+ stem cells. These
particular haematological stem cells have a
great capacity to repopulate the bone marrow
and now are being used to intent an alterna-
tive approach to several both malignant and
not haematological disease. So, by using this
procedure, after several laboratory passages of
CD34+ recovering, metabolism monitoring,
enrichment and clonogenic culture, we aim at
trying to get a complete marrow reconstitution
of the thalassemic mother, thanks to the help
offered by her donor son. 
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Figure 3. Photograph showing the collec-
tion of umbilical cord blood, containing a
large quantity of CD34+ stem cells, during
a caesarean section, in a thalassemic
woman. 
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